Filed Jan. 8, 2024

Serial No. 79392428

Registered April 29, 2025

Registration No. 7,772,720

Class pharmaceutical substances for the treatment of cancer, infectious diseases, and autoimmune diseases; pharmaceutical substances for the prevention of cancer, infectious diseases, and autoimmune diseases; pharmaceutical preparations for the treatment of cancer, infectious diseases, and autoimmune diseases; pharmaceutical preparations for the prevention of cancer, infectious diseases, and autoimmune diseases; pharmaceutical products for the treatment of cancer, infectious diseases, and autoimmune diseases; pharmaceutical products for the prevention of cancer, infectious diseases, and autoimmune diseases; pharmaceutical substances, pharmaceutical preparations and pharmaceutical products for the induction of immune tolerance, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunotherapeutics, namely, pharmaceutical products for the treatment of cancer and infectious diseases, and autoimmune diseases; immunotherapeutics, namely, pharmaceutical products for the prevention of cancer and infectious diseases, and autoimmune diseases; vaccines; viral vaccines; vaccines for prevention against influenza; therapeutic vaccines for the treatment of influenza; vaccines for prevention against infectious diseases; therapeutic vaccines for the treatment of infectious diseases; vaccines for prevention against cancer; therapeutic vaccines for the treatment of cancer; viral antigens in the nature of biological tissue cultures for medical purposes; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark